SPDR S&P Biotech (NYSEARCA:XBI) saw unusually large options trading activity on Tuesday. Investors purchased 2,063 call options on the company. This represents an increase of approximately 265% compared to the average daily volume of 565 call options.
Shares of SPDR S&P Biotech (XBI) traded up 2.41% during trading on Tuesday, reaching $75.95. 3,505,901 shares of the company traded hands. SPDR S&P Biotech has a 12 month low of $49.51 and a 12 month high of $76.59. The firm has a 50-day moving average price of $70.31 and a 200-day moving average price of $67.30.
The business also recently disclosed a quarterly dividend, which will be paid on Monday, June 26th. Stockholders of record on Tuesday, June 20th will be paid a $0.1101 dividend. This is an increase from SPDR S&P Biotech’s previous quarterly dividend of $0.02. The ex-dividend date is Friday, June 16th. This represents a $0.44 annualized dividend and a dividend yield of 0.59%.
WARNING: “SPDR S&P Biotech Sees Unusually Large Options Volume (XBI)” was reported by Stock Observer and is the property of of Stock Observer. If you are accessing this piece on another website, it was illegally copied and republished in violation of U.S. and international trademark & copyright law. The legal version of this piece can be read at https://www.thestockobserver.com/2017/06/20/spdr-sp-biotech-sees-unusually-large-options-volume-xbi-updated.html.
SPDR S&P Biotech Company Profile
SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.
Receive News & Ratings for SPDR S&P Biotech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SPDR S&P Biotech and related companies with MarketBeat.com's FREE daily email newsletter.